Back Medical Oncology department

OUR TREATMENTS

Chemotherapy is a treatment in which one or more anti-tumorous drugs are combined and administered to destroy tumorous cells and reduce the disease, by using a wide variety of drugs.

Some tumours, mainly, breast and prostate cancer have receptors in the tumorous cells which make them ´sensitive´ to certain hormones, stimulating growth.

The immune system is fundamental in the development and control of tumours. Immunotherapy repairs or increases the response of the patient´s immune system.

Biological therapy treatments use specially designed drugs to block specific aspects of the tumour´s biological make-up. 

REQUEST A SECOND OPINION?

Imagen con los pasos que hay que dar para solicitar una segunda opinión en la Clínica Universidad de Navarra

If you require the opinion of our experts without having to travel to the Clinica, we offer the possibility of a Second Medical Opinion consultation.

The aim of chemotherapy is to destroy tumorous cells and reduce the effects of the disease.

Chemotherapy is a systematic treatment in which one or more anti-tumorous drugs are combined and administered.

The objective is to destroy tumorous cells in order to decrease the disease´s effect, using a wide variety of drugs. Although just one form of medication can be used, in general, these drugs are more effective when used in certain combinations.

The cancerous cells grow and divide quickly. Chemotherapy stops and delays the growth of these cancerous cells.

This treatment can be used as an adjuvant, neoadjuvant (before surgery on the tumour) and for diseases which have spread, to control the metastasis from a distance.

Selecting the most appropriate chemotherapy treatment scheme depends on the size of the tumour, how the nodes are affected, whether there is a metastasis, previous treatments, the tumorous subtype of the cancer, age, comorbidities, the health status of the patient and the potential toxicity. 

Some tumours are sensitive to certain hormones which stimulate their growth.

Certain tumours, mainly, breast and prostate cancer have receptors in the tumorous cells which make them ´sensitive´ to certain hormones, (oestrogen for breast cancer and testosterone for prostate cancer), stimulating growth.

Hormone therapy treatment is divided into two types:

  • Treatment which inhibits the production of hormones. It aims to inhibit the production of these hormones either with radiotherapy on the ovaries or testicles, or using drugs
  • Treatment that blocks the actions of the receptors. The objective of this treatment is different and blocks the hormonal receptors present in the tumorous cells so that the hormones aren´t able to activate them.

Immunotherapy repairs and increases the response of the patient´s immune system.

The immune system is fundamental in the development and control of tumours. Immunotherapy aims to repair and increase the response of the patient´s immune system.

Vaccines are a type of active immunotherapy which produce a response when faced with tumorous antigens. The volume of the disease is limited and the use of both chemotherapy and immunotherapy makes this a good option as an additional treatment for patients with certain types of tumours, a localised disease or for those who require chemotherapy treatment.

The vaccines are created in the GMP laboratory for Cell Therapy at the Clínica with cells extracted from the patient themselves. 

Biological therapy treatments use specially designed drugs to block specific aspects of the tumour´s biological make-up.

Biological Therapies are treatments directed at those which, unlike chemotherapy, use specially designed drugs to block specific aspects of the tumour´s biological make-up.

In this way, biological therapies are more selective of tumorous cells, produce less side effects than, for example, chemotherapy, and this means higher doses of the drugs can be administered.

We currently have different drugs which act on the hyperactive signalling pathways in the tumorous cells, either on an extracellular or intracellular basis. 

you maybe interested

WHY CHOOSE US

Learn why the Clínica Universidad de Navarra is different from other hospitals.

Imagen de una niña pequeña con cáncer por los pasillos de la Clínica

CLINICAL TRIALS

Want to participate in our clinical trials? Learn which ones are active.

Imagen médico investigando con microscopio

INTERNATIONAL SERVICES

Know what we do for our international patients

Entrada principal a la Clínica Universidad de Navarra